1. Home
  2. EM vs MDWD Comparison

EM vs MDWD Comparison

Compare EM & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smart Share Global Limited

EM

Smart Share Global Limited

HOLD

Current Price

$1.35

Market Cap

286.5M

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$18.97

Market Cap

230.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EM
MDWD
Founded
2017
2000
Country
China
Israel
Employees
N/A
N/A
Industry
Other Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
286.5M
230.7M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
EM
MDWD
Price
$1.35
$18.97
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$1.25
$37.50
AVG Volume (30 Days)
715.7K
96.8K
Earning Date
11-26-2025
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$259,541,587.00
$20,932,000.00
Revenue This Year
$3.30
$15.89
Revenue Next Year
$5.26
$25.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
6.15
52 Week Low
$0.68
$14.14
52 Week High
$1.46
$22.51

Technical Indicators

Market Signals
Indicator
EM
MDWD
Relative Strength Index (RSI) 45.32 59.99
Support Level $1.34 $18.71
Resistance Level $1.40 $19.63
Average True Range (ATR) 0.03 0.71
MACD -0.00 0.18
Stochastic Oscillator 21.43 79.22

Price Performance

Historical Comparison
EM
MDWD

About EM Smart Share Global Limited

Smart Share Global Ltd is a consumer tech company providing mobile device charging services through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Geographically, the company generates revenue from the PRC. The company has two segments, the mobile device charging segment and the PV business segment. The company generates the majority of its revenue from the mobile device charging segment.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: